查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1313428

即时 PCR 市场：2023-2030 年全球预测（按产品（仪器、试剂和消耗品、软体和服务）、用途（临床、法医学、研究）和最终用户）

Real-time PCR Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Forensics, Research), End Users - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年全球实时PCR市场将达到344,599万美元，复合年复合成长率为9.67%，预计2030年将达到惊人的660761万美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球即时PCR市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.实时PCR的全球市场规模和预测是多少？

2. 在预测期内，COVID-19 对全球即时 PCR 市场的阻碍因素与影响有哪些？

3. 在预测期内，全球即时 PCR 市场需要投资哪些产品/细分市场/用途/领域？

4.全球即时PCR市场的竞争策略为何？

5. 全球即时PCR市场的技术趋势和法律规范是什么？

6.全球实时PCR市场主要厂商的市占率为何？

7. 哪些型态和策略措施被认为适合进入全球即时PCR市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 感染疾病和遗传疾病的传播
      • 快速利用生物标记分析进行疾病诊断
      • 早期诊断致病微生物并增加临床诊断测试的使用
    • 抑制因素
      • 与实时 PCR 相关的设备成本高昂
    • 机会
      • 持续技术整合和开发紧凑型便携式晶片实验室 PC 设备
      • 从植物来源的药物发现快速转变为基于基因组的药物研发
    • 任务
      • 实时PCR方法的技术限制和缺乏熟练的专家
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章即时 PCR 市场：副产品

  • 介绍
  • 装置
  • 试剂及消耗品
  • 软体和服务

第7章即时 PCR 市场：依用途

  • 介绍
  • 临床
  • 法医学
  • 研究

第8章即时 PCR 市场：依最终用户分类

  • 介绍
  • 临床研究所
  • 法医学研究所
  • 医院和诊断中心
  • 製药和生物技术公司
  • 研究和学术机构

第9章美洲实时PCR市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太实时PCR市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东和非洲实时PCR市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-0D217D5AEDCE

The Global Real-time PCR Market is forecasted to grow significantly, with a projected USD 3,445.99 million in 2023 at a CAGR of 9.67% and expected to reach a staggering USD 6,607.61 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Real-time PCR Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Real-time PCR Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Instruments, Reagents & Consumables, and Software & Services. The Reagents & Consumables is projected to witness significant market share during forecast period.

Based on Application, market is studied across Clinical, Forensics, and Research. The Clinical is projected to witness significant market share during forecast period.

Based on End Users, market is studied across Clinical Research Organizations, Forensic Laboratories, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, and Research Laboratories & Academic Institutes. The Forensic Laboratories is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Real-time PCR Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Real-time PCR Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Real-time PCR Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Real-time PCR Market?

4. What is the competitive strategic window for opportunities in the Global Real-time PCR Market?

5. What are the technology trends and regulatory frameworks in the Global Real-time PCR Market?

6. What is the market share of the leading vendors in the Global Real-time PCR Market?

7. What modes and strategic moves are considered suitable for entering the Global Real-time PCR Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Real-time PCR Market, by Product, 2022 vs 2030
  • 4.3. Real-time PCR Market, by Application, 2022 vs 2030
  • 4.4. Real-time PCR Market, by End Users, 2022 vs 2030
  • 4.5. Real-time PCR Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of infectious diseases and genetic disorders
      • 5.1.1.2. Rapid utilization of biomarker profiling for disease diagnostics
      • 5.1.1.3. Rising early diagnosis of disease-causing microbes and the use of clinical diagnostic tests
    • 5.1.2. Restraints
      • 5.1.2.1. High device costs associated with real-time PCR
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technological integration and development of compact, portable, and lab-on-chip PCR devices
      • 5.1.3.2. Rapid shift from plant-derived to genome-based drug discovery
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations of real-time PCR techniques and lack of skilled professionals
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Real-time PCR Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Consumables
  • 6.4. Software & Services

7. Real-time PCR Market, by Application

  • 7.1. Introduction
  • 7.2. Clinical
  • 7.3. Forensics
  • 7.4. Research

8. Real-time PCR Market, by End Users

  • 8.1. Introduction
  • 8.2. Clinical Research Organizations
  • 8.3. Forensic Laboratories
  • 8.4. Hospitals & Diagnostic Centers
  • 8.5. Pharmaceutical & Biotechnology Companies
  • 8.6. Research Laboratories & Academic Institutes

9. Americas Real-time PCR Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Real-time PCR Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Real-time PCR Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. REAL-TIME PCR MARKET RESEARCH PROCESS
  • FIGURE 2. REAL-TIME PCR MARKET SIZE, 2022 VS 2030
  • FIGURE 3. REAL-TIME PCR MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. REAL-TIME PCR MARKET SIZE, BY END USERS, 2022 VS 2030 (%)
  • FIGURE 7. REAL-TIME PCR MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. REAL-TIME PCR MARKET DYNAMICS
  • FIGURE 9. REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. REAL-TIME PCR MARKET SIZE, BY END USERS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES REAL-TIME PCR MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. REAL-TIME PCR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. REAL-TIME PCR MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. REAL-TIME PCR MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. REAL-TIME PCR MARKET SIZE, BY FORENSICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. REAL-TIME PCR MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 13. REAL-TIME PCR MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. REAL-TIME PCR MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. REAL-TIME PCR MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. REAL-TIME PCR MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES REAL-TIME PCR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 145. REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 146. REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 147. REAL-TIME PCR MARKET LICENSE & PRICING